NOX5 and posterior cortical atrophy: Using a Nox5 antibody validated by stringent biochemical criteria, we demonstrate herein that Nox5 is abundantly expressed in both benign prostate epithelia and in clinical PCa, although not at statistically different levels between patient‐matched benign and malignant prostate tissues.